The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on nerves throughout the body. The federal agency said on Tuesday it greenlighted SpringWorks Therapeutics’s drug Gomekli for patients dealing with neurofibromatosis type 1 (NF1) “who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.” …
Source link
FDA approves new genetic disorder drug
Date:
Share post:
More like thisRelated
Netanyahu “looking for excuse [to] restart war” in Gaza
Khaled Elgindy, talks about Trump’s statement that, that,...
Top U.S. & World Headlines — January 20, 2025
Support our work: https://democracynow.org/donate/sm-desc-yt Democracy Now! is an independent...
Trump vows to revitalize DC while warring with Washington workforce
President Donald Trump loves to hate Washington, D.C.,...
🔴Today News| Nepali News|आज माघ २३ गते Aajaka Mukhya Samachar, Nepali Samachar|Magh 23 #newsinnepal
This is a fully news and entertainment channel. It...